Tag: Food and Drug Administration (FDA)
FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants and Small Children
The new epinephrine auto-injector would feature a lower dose and shorter needle length suitable for smaller children.
Approval of Adamis Emergency Epinephrine Solution Expected Next Month
The market is anticipating FDA approval of a novel method of delivering emergency epinephrine.
Company Seeks to Remove the Allergist from Treating Food Allergy
AllergyEasy manufactures drops used in sublingual immunotherapy, not approved by the FDA for the treatment of food allergy.
Adamis Pre-Filled Syringe: Is Third Time a Charm?
An alternative to the epinephrine auto-injector has been accepted by the FDA for consideration.
Report: Panel Urges Revamp of Allergen Label Warnings
The National Academies of Sciences, Engineering and Medicine recommends changes to our ambiguous system of voluntary labeling.
FDA Director Responds to Auto-Injector Pricing Concerns
The FDA's official response concerning the pricing of EpiPen being investigated by congress.
Epinephrine Auto-injectors: Where is the Long Promised Generic?
We were supposed to have a generic alternative last year. What's holding it up and when can we expect it?
Common Additive May Be a Cause of Food Allergy
Could tert-butylhydroquinone (tBHQ) be responsible for the meteoric rise in food allergies? A researcher from the University of Michigan thinks so.
Adamis Auto-Injector Rejected by FDA
More study required as result of changes made to product in response to prior rejection.
Delivering the Next Generation Auto-Injector
CEO Christopher Stepanian tells us how Windgap's auto-injector seeks to 'improve the quality of life for patients living with severe allergies.'
